Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance
Autor: | Anna Pavlova-Wolf, Kenneth Lieberman |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Nephrology
Adult medicine.medical_specialty Pediatrics Nephrotic Syndrome Adolescent 030232 urology & nephrology MEDLINE Diuresis Adrenocorticotropic hormone Review 030204 cardiovascular system & hematology Idiopathic Nephrotic Syndrome 03 medical and health sciences Young Adult 0302 clinical medicine Adrenocorticotropic Hormone Internal medicine medicine Humans Young adult Child Pediatric Proteinuria business.industry medicine.disease Immunology Systematic review medicine.symptom business Nephrotic syndrome |
Zdroj: | Journal of Nephrology |
ISSN: | 1724-6059 1121-8428 |
Popis: | Adrenocorticotropic hormone (ACTH) as a treatment for proteinuria due to nephrotic syndrome (NS) has re-emerged over the last decade. Current clinical data are primarily limited to adults with treatment-resistant NS. Largely unknown to today’s clinicians is the existence of early clinical studies, following ACTH’s introduction in the late 1940s, showing sustained proteinuria response in idiopathic NS in predominantly pediatric, treatment-naïve patients. Before ACTH, patients suffered severe edema and high mortality rates with no reliable or safe treatment. ACTH dramatically altered NS management, initially through recognition of diuresis effects and then through sustained proteinuria remission. This review synthesizes early clinical literature to inform current NS patient management. We undertook a MEDLINE search using MeSH terms “adrenocorticotropic hormone” and “nephrotic syndrome,” with limits 1945–1965 and English. Sixty papers totaling 1137 patients were found; 14 studies (9 short-term, five long-term, N = 419 patients) met inclusion criteria. Studies were divided into two groups: short-term (≤28 days) and long-term (>5 weeks; short-term initial daily treatment followed by long-term intermittent)ACTH therapy and results were aggregated. An initial response, defined as a diuresis, occurred in 74 % of patients/treatment courses across nine short-term ACTH studies. Analyzed in eight of these studies, proteinuria response occurred in 56 % of patients/treatment courses. Across five long-term ACTH studies, proteinuria response was shown in 71 % of patients and was sustained up to 4.7 years following treatment. The inventory and re-evaluation of early clinical data broadens the evidence base of clinical experiences with ACTH for implementation of current treatment strategies and aiding the design of future studies. Electronic supplementary material The online version of this article (doi:10.1007/s40620-016-0308-3) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |